Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
Not Applicable
Recruiting
- Conditions
- Amputation
- First Posted Date
- 2025-02-21
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 45
- Registration Number
- NCT06840262
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry
Not yet recruiting
- Conditions
- Thoracic Tumors
- First Posted Date
- 2025-02-21
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 250
- Registration Number
- NCT06840288
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
The Effect of the Prostate Cancer Foundation Screening Guidelines for Black Men on Intention to Screen in Faith-based Communities
Recruiting
- Conditions
- Prostate Cancer Screening
- First Posted Date
- 2025-02-20
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT06838325
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
- First Posted Date
- 2025-02-14
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT06826768
- Locations
- 🇺🇸
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
- First Posted Date
- 2025-02-10
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT06817720
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study
Phase 2
Recruiting
- Conditions
- Acute Myeloid Leukemia (AML)
- Interventions
- First Posted Date
- 2025-02-06
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 140
- Registration Number
- NCT06811233
- Locations
- 🇺🇸
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation
Phase 2
Recruiting
- Conditions
- Hematologic Malignancies
- Interventions
- Drug: Drugs Cyclophosphamide
- First Posted Date
- 2025-02-04
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 35
- Registration Number
- NCT06807606
- Locations
- 🇺🇸
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
- First Posted Date
- 2025-02-04
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT06807593
- Locations
- 🇺🇸
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
- First Posted Date
- 2025-01-30
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT06801041
- Locations
- 🇺🇸
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
Recruiting
- Conditions
- Prostate Cancer
- First Posted Date
- 2025-01-21
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 180
- Registration Number
- NCT06785441
- Locations
- 🇺🇸
M.D. Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath